Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
8.5
423.95%
80%
—
214.27%
Every year
—
5 Years
Score8.5
Net Growth423.95%
Net Trend80%
Net Income Consistency—
Rev Growth214.27%
Rev TrendEvery year
Revenue Consistency—
Harmony Biosciences Holdings fundamental performance
Between 2020 and 2025, revenue grew from $ 159M to $ 868M and net income went from -$ 36M to $ 158M. Revenue increased in every one of those 5 years; net income in 4.
Harmony Biosciences Holdings currently holds a 5-year HDB Score of 8.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 39.77 | — |
1 Year2025-08-12 | $ 35.47 | 12.12% |
5 Years2021-08-12 | $ 31.74 | 25.30% |
All Time2020-08-19 | $ 37.01 | 7.46% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-08-19 |
|---|---|---|---|---|
| Price | $ 39.77 | $ 35.47 | $ 31.74 | $ 37.01 |
| Return | — | 12.12% | 25.30% | 7.46% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 959M | $ 181M | $ 667M |
| 2025 | $ 868M | $ 158M | $ 775M |
| 2024 | $ 714M | $ 145M | $ 467M |
| 2023 | $ 582M | $ 128M | $ 353M |
| 2022 | $ 437M | $ 181M | $ 323M |
| 2021 | $ 305M | $ 34M | $ 234M |
| IPO2020 | $ 159M | -$ 36M | $ 228M |
Explore beyond HRMY
You're looking at Harmony Biosciences Holdings. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
